No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5571 |
4. Check minimum number of eventsNone |
5571 |
5. Include endpointsNone |
5571 |
6. Filter based on genotype QC (FinnGen only) |
5571 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Poor fetal growth
based on the number of shared cases.
Similar with more cases:
- Pre-eclampsia or poor fetal growth
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 42702 | 42702 | - |
| Only index persons | 42233 | 42233 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.22 | 1.22 | - |
| Only index persons | 1.55 | 1.55 | - |
| Median age at first event (years) | |||
| Whole population | - | 29.46 | - |
| Only index persons | - | 29.43 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5571 | 5571 | - |
| Unadjusted period prevalence (%) | 1.90 | 1.90 | - |
| Median age at first event (years) | 30.18 | 30.18 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4833
- Matched controls
- 48329
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
6565A
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]
+∞
323.0
449
*
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
14773.6
323.0
4191
11
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
3.7
292.4
1637
5919
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
3.6
287.4
1631
5947
6565B
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]
+∞
274.6
261
*
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.7
213.5
2287
12220
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.9
209.0
1625
7116
O41.0
ICD-10 Finland
Oligohydramnios
6.6
184.5
510
852
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.3
163.1
2882
18935
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
3.5
149.2
799
2602
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
2.2
143.2
2121
12535
SPAT1379
SPAT
Health check-up of pregnant person
2.3
131.3
1677
9142
Z39.2
ICD-10 Finland
Routine postpartum follow-up
2.1
119.8
1838
10776
SPAT1197
SPAT
Extensive health check-up of expecting family
2.1
114.0
1843
10988
SPAT1380
SPAT
Postpartum check-up
2.2
111.6
1437
7736
W78
ICPC
Pregnancy
2.0
107.2
1997
12526
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
2.8
101.7
761
3058
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.2
98.3
1178
6070
XMA22
NOMESCO Finland
General examination of pregnant woman
2.5
96.3
844
3707
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.9
94.0
2789
20382
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
2.5
92.6
822
3626
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
2.5
92.4
819
3612
O32.1
ICD-10 Finland
Maternal care for breech presentation
2.8
91.4
648
2506
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
4.0
89.0
378
992
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
1.9
83.7
1758
11230
O80.8
ICD-10 Finland
Other single spontaneous delivery
2.6
81.8
672
2823
ZXD05
NOMESCO Finland
Urgent procedure
1.8
81.0
1881
12403
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
2.2
74.7
873
4372
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.0
74.2
1259
7364
W84
ICPC
Pregnancy high risk
2.7
73.8
554
2202
O14.1
ICD-10 Finland
Severe pre-eclampsia
6.4
70.0
191
307
O60
ICD-10 Finland
Preterm labour and delivery
3.2
68.9
401
1347
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
3.9
64.2
279
744
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
1.8
59.6
1277
8000
O82.0
ICD-10 Finland
Delivery by elective caesarean section
2.4
59.6
573
2589
SPAT1196
SPAT
Monitoring of normal pregnancy
2.0
59.2
957
5426
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.9
57.4
1100
6623
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
2.9
57.1
366
1310
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
2.2
57.1
658
3241
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
3.4
56.6
298
929
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.6
56.3
443
1798
MAA00
NOMESCO Finland
Amniocentesis
3.1
54.3
318
1070
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
3.3
50.9
270
846
8811
FHL
Cesarean section
2.7
48.9
364
1425
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
3.7
48.0
220
613
WX320
NOMESCO Finland
Spinalanesthesy
1.8
47.7
962
5842
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.7
45.3
1187
7793
MAC96
NOMESCO Finland
Other induction or advancement of labour
2.5
43.5
356
1472
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
4.0
40.8
169
432
MAX99
NOMESCO Finland
Assistance to normal delivery
1.7
40.2
1104
7305
C07AG01
ATC
labetalol; systemic
4.2
38.7
152
370
W90
ICPC
Uncompl labour/delivery livebirth
2.0
37.9
563
3045
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
3.5
34.2
164
476
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
2.7
34.0
246
945
O30.0
ICD-10 Finland
Twin pregnancy
2.9
33.8
213
752
O99.80
ICD-10 Finland
The fear of childbirth
1.9
33.2
577
3293
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
2.6
32.5
246
971
ZXE00
NOMESCO Finland
One hour or less
1.5
32.3
1904
14907
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.6
31.3
244
980
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.5
30.7
255
1060
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
1.5
30.6
1369
10090
W92
ICPC
Compl labour/ delivery livebirth
2.4
30.1
279
1226
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
1.6
29.5
978
6720
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
2.5
28.9
233
953
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
28.3
1973
15826
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
2.6
27.6
205
801
O20.0
ICD-10 Finland
Threatened abortion
2.2
27.0
276
1271
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
2.1
27.0
324
1606
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
1.8
26.5
480
2771
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
4.1
26.5
104
255
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
3.2
25.6
138
440
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.6
25.5
707
4623
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.5
25.5
881
6086
SPAT1263
SPAT
Sampling
1.4
25.3
1981
16111
SPAT1357
SPAT
Monitoring of problem during pregnancy
2.0
25.3
341
1770
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.5
25.3
865
5963
O36.3
ICD-10 Finland
Maternal care for signs of fetal hypoxia
4.2
24.9
95
227
SPAT1189
SPAT
Other ultrasound examination during pregnancy
1.9
24.9
378
2052
O02.1
ICD-10 Finland
Missed abortion
1.7
23.7
532
3277
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
2.4
23.6
205
871
MA3AE
NOMESCO Finland
Combined first trimester screening
1.7
23.1
489
2960
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
1.7
23.0
494
3001
SPAT1301
SPAT
No procedures
1.4
22.8
1236
9367
6563B
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, SYNNYTYKSEN AIKANA]
3.1
22.2
124
406
O30.00
ICD-10 Finland
Twin pregnancy with separate amniotic and chorionic sacs
4.6
21.8
77
171
Z36.4
ICD-10 Finland
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
2.5
21.7
172
698
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
3.4
21.5
104
307
C08CA05
ATC
nifedipine; systemic
2.3
21.0
204
918
O36.4
ICD-10 Finland
Maternal care for intrauterine death
4.2
20.8
79
189
W29
ICPC
Pregnancy symptom/complaint other
2.0
20.8
294
1553
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
1.7
20.0
446
2738
O35.6
ICD-10 Finland
Maternal care for (suspected) damage to fetus by radiation
73.8
19.7
22
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.6
19.6
612
4106
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
5.4
19.4
58
108
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
2.7
19.4
133
499
FM1NE
NOMESCO Finland
Ultrasound examination of fetal heart
4.1
19.4
76
188
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
1.8
19.3
369
2161
O43.8
ICD-10 Finland
Other placental disorders
11.7
19.2
35
30
6563A
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, RASKAUDEN AIKANA]
11.7
19.2
35
30
O47.9
ICD-10 Finland
False labour, unspecified
2.3
19.1
186
838
ZXD00
NOMESCO Finland
Emergency procedure
2.2
18.6
199
938
WX307
NOMESCO Finland
Obstetric epidural analgesia
1.4
18.4
861
6299
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
3.2
18.4
98
312
Z39.1
ICD-10 Finland
Care and examination of lactating mother
2.1
18.1
221
1103
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
18.1
1431
11478
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
3.5
18.0
83
237
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
1.7
17.4
397
2452
O72.2
ICD-10 Finland
Delayed and secondary postpartum haemorrhage
2.2
16.6
170
788
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
2.0
16.6
213
1084
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
3.1
16.4
91
299
6423A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]
3.6
16.3
74
209
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
2.1
16.2
181
870
6425A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]
7.6
16.1
37
49
6424A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]
3.7
16.0
69
187
6420X
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium
6.6
15.8
40
61
6440B
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]
3.2
15.8
84
269
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
2.5
15.8
128
530
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
1.8
15.7
254
1408
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
15.4
2007
17198
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.4
15.2
801
5971
WX290
NOMESCO Finland
Other blockade of nerve
1.3
15.0
2460
21670
O68.8
ICD-10 Finland
Labour and delivery complicated by other evidence of fetal stress
2.7
15.0
102
382
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
1.8
14.7
277
1615
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
2.2
14.2
152
718
O30.01
ICD-10 Finland
Twin pregnancy with a shared chorionic sac and a separate amniotic sac
6.8
14.2
35
52
O84.0
ICD-10 Finland
Multiple delivery, all spontaneous
3.2
14.1
74
235
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
14.0
803
6073
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
2.6
14.0
100
387
Z30.2
ICD-10 Finland
Sterilization
1.4
13.9
615
4434
Z72.0
ICD-10 Finland
Tobacco use
2.4
13.9
115
480
K02.1
ICD-10 Finland
Caries of dentine
1.3
13.7
2863
25854
SPAT1200
SPAT
Guidance for breast-feeding and breast care
1.7
13.6
285
1720
SPAT1246
SPAT
Screening of depression or other psychiatric problem
1.6
13.5
380
2477
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
1.6
13.1
312
1947
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
5.8
13.1
36
62
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
2.4
13.1
108
453
O45.9
ICD-10 Finland
Premature separation of placenta, unspecified
4.5
13.1
45
100
B01AB05
ATC
enoxaparin; parenteral
1.3
12.8
873
6784
WX234
NOMESCO Finland
Paracervical blockade
1.7
12.7
272
1648
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
12.7
1709
14590
O64.1
ICD-10 Finland
Obstructed labour due to breech presentation
2.1
12.6
149
738
O16
ICD-10 Finland
Unspecified maternal hypertension
3.7
12.6
53
143
6580A
ICD-9 Finland
Other problems associated with amniotic cavity and membranes, Oligohydramnios[OLIGOHYDRAMNION, RASKAUDEN AIKANA]
11.0
12.5
23
21
Z3232
NOMESCO Finland
Midwife
1.3
12.4
865
6740
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
1.9
12.4
187
1016
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
12.4
2503
22379
SPAT1315
SPAT
Periodic health check-up of children and adolescents
1.6
12.3
320
2048
SPAT1310
SPAT
Counselling related to known health issue
1.3
12.3
1269
10459
SPAT1307
SPAT
Psychosocial counselling and guidance
1.5
12.2
435
2998
G02CB01
ATC
bromocriptine; systemic
2.1
12.2
138
669
MAA10
NOMESCO Finland
Biopsy of chorionic villus
4.1
11.8
45
111
SPAT1312
SPAT
General health counselling
1.3
11.8
1424
11968
J01CA08
ATC
pivmecillinam; oral
1.2
11.5
2305
20514
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
1.8
11.4
199
1137
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
1.6
11.4
262
1624
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
2.0
11.3
138
693
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
11.2
3505
32735
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
3.2
11.2
56
174
V230A
ICD-9 Finland
Supervision of high-risk pregnancy, Pregnancy with history of infertility
3.2
11.2
58
185
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.7
11.2
237
1436
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
11.1
2289
20407
SPAT1391
SPAT
Counselling and guidance related to family situation
2.1
11.0
116
550
MAG00
NOMESCO Finland
Assisted breech delivery
2.8
10.9
68
242
P01AB01
ATC
metronidazole; oral, rectal
1.2
10.8
1827
15929
Z37.0
ICD-10 Finland
Single live birth
1.3
10.7
908
7270
O80.1
ICD-10 Finland
Spontaneous breech delivery
2.5
10.6
79
316
O44.0
ICD-10 Finland
Placenta praevia specified as without haemorrhage
2.4
10.6
85
353
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
10.5
1216
10136
N02BE01
ATC
paracetamol; systemic, rectal
1.3
10.4
3714
35020
SPAT1240
SPAT
Therapeutic discussion
1.4
10.4
658
5042
O10.9
ICD-10 Finland
Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium
4.7
10.2
33
70
O20.8
ICD-10 Finland
Other haemorrhage in early pregnancy
2.8
10.1
64
234
SPAT1260
SPAT
Consultation of another employee
1.4
10.1
628
4802
N07BA03
ATC
varenicline; oral
1.7
10.0
217
1322
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
2.5
10.0
75
301
Z31.5
ICD-10 Finland
Genetic counselling
1.5
10.0
318
2139
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
1.6
9.9
231
1437
SPAT1153
SPAT
Removal of sutures
1.3
9.9
885
7128
Z37.2
ICD-10 Finland
Twins, both liveborn
3.6
9.9
42
116
WX110
NOMESCO Finland
Local anesthesy
1.2
9.7
3251
30281
A02BC01
ATC
omeprazole; systemic
1.3
9.7
892
7213
J01DB01
ATC
cefalexin; oral
1.3
9.7
3755
35534
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
2.2
9.7
96
444
XMA20
NOMESCO Finland
Early examination of pregnancy
2.0
9.7
113
561
O34.3
ICD-10 Finland
Maternal care for cervical incompetence
2.8
9.6
58
207
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
3.4
9.4
43
126
SPAT1272
SPAT
Drug screening
4.1
9.4
35
86
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
9.3
860
6953
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
9.2
1047
8694
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
1.9
9.1
138
754
C07AB02
ATC
metoprolol; systemic
1.5
9.1
342
2385
MAC98
NOMESCO Finland
Other induction of labor
6.5
8.9
22
34
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
8.9
2753
25314
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
1.3
8.9
552
4214
MBA30
NOMESCO Finland
Manual removal of placenta from delivered uterus
1.8
8.8
141
787
K04.0
ICD-10 Finland
Pulpitis
1.4
8.8
515
3896
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
2.1
8.7
97
474
SPAT1373
SPAT
Combined screening in early pregnancy
1.7
8.7
172
1023
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
8.6
3274
30664
O03.6
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, complicated by delayed or excessive haemorrhage
2.4
8.5
69
290
Z32
ICD-10 Finland
Pregnancy examination and test
2.2
8.5
85
395
MBC10
NOMESCO Finland
Repair of obstetric laceration of vagina
1.7
8.5
165
978
SPAT1192
SPAT
Gynaecological examination
1.3
8.5
877
7185
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
2.0
8.5
100
501
J01DA01
ATC
[U] cefalexin; systemic
1.2
8.4
2732
25170
Z36.5
ICD-10 Finland
Antenatal screening for isoimmunization
12.8
8.4
14
11
Z34
ICD-10 Finland
Supervision of normal pregnancy
1.4
8.3
430
3181
WYA40
NOMESCO Finland
Assessment of oral health and treatment needs for family expecting first child
1.7
8.3
162
963
SPAT1283
SPAT
Restricted health certificate
1.2
8.3
1299
11159
O44.1
ICD-10 Finland
Placenta praevia with haemorrhage
2.5
8.3
62
252
6425B
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]
5.5
8.3
23
42
O34.0
ICD-10 Finland
Maternal care for congenital malformation of uterus
3.1
8.2
42
135
6510A
ICD-9 Finland
Multiple gestation, Twin pregnancy[GEMINI, RASKAUDEN AIKANA]
4.4
8.2
28
64
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
2.3
8.1
70
307
MAB20
NOMESCO Finland
Failed external version
1.9
8.1
113
602
WZB00
SPAT
NA
0.6
8.0
107
1804
SPAT1303
SPAT
Counselling and guidance related to growth and development
2.1
8.0
82
388
W03
ICPC
Antepartum bleeding
2.2
7.9
77
356
6522B
ICD-9 Finland
Malposition and malpresentation of foetus, Breech presentation without mention of version[PRAESENTATIO CLUNIUM,SYNNYTYKSEN AIKANA]
2.1
7.9
82
390
MAC02
NOMESCO Finland
Rupture of aminiotic membrane for advancement of labor
2.7
7.9
51
190
Z35.6
ICD-10 Finland
Supervision of very young primigravida
3.9
7.8
30
77
MBA20
NOMESCO Finland
Expression of placenta
2.3
7.6
69
308
R51.80
ICD-10 Finland
Headache
1.3
7.6
727
5894
O61.0
ICD-10 Finland
Failed medical induction of labour
2.0
7.5
92
465
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
2.7
7.5
48
177
NE1AG
NOMESCO Finland
MRI pelvimetry with high intensity magnet
2.2
7.5
71
325
Z29
ICPC
Social problem NOS
1.9
7.5
98
512
O00.1
ICD-10 Finland
Tubal pregnancy
1.7
7.4
136
794
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
2.4
7.4
61
260
O04.6
ICD-10 Finland
Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage
1.9
7.3
95
497
MAB10
NOMESCO Finland
External version
2.3
7.2
63
277
W27
ICPC
Fear of complications of pregnancy
1.9
7.2
96
506
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.8
7.1
113
630
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
7.0
2432
22368
W05
ICPC
Pregnancy vomiting/nausea
2.0
7.0
84
425
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
7.0
1001
8496
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
4.0
6.9
26
66
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
6.9
307
2213
O73.1
ICD-10 Finland
Retained portions of placenta and membranes, without haemorrhage
2.3
6.9
61
269
W99
ICPC
Disorder of pregn/delivery other
2.8
6.9
42
153
D68.8
ICD-10 Finland
Other specified coagulation defects
2.3
6.9
58
249
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
6.8
207
1385
O43.9
ICD-10 Finland
Placental disorder, unspecified
9.3
6.8
13
14
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
6.7
350
2595
O81.4
ICD-10 Finland
Vacuum extractor delivery
1.3
6.7
499
3909
P19
ICPC
Drug abuse
2.6
6.7
47
184
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.2
6.6
64
295
O69.8
ICD-10 Finland
Labour and delivery complicated by other cord complications
5.9
6.6
17
29
O45.8
ICD-10 Finland
Other premature separation of placenta
4.2
6.6
23
55
Z12
ICPC
Relationship problem with partner
1.7
6.6
121
709
O31.8
ICD-10 Finland
Other complications specific to multiple gestation
12.2
6.6
11
9
G03DA04
ATC
progesterone; systemic, rectal, vaginal
1.6
6.5
167
1073
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.4
6.5
342
2544
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
2.8
6.5
39
142
O21.1
ICD-10 Finland
Hyperemesis gravidarum with metabolic disturbance
2.9
6.4
37
128
R2110
NOMESCO Finland
Giving the first information
1.4
6.4
365
2746
6412B
ICD-9 Finland
Antepartum haemorrhage, abruptio placentae and placenta praevia, Premature separation of placenta[ABLATIO PLACENTAE ANTETEMPUS,SYNN PÄÄTT HOITOJAKSO]
5.7
6.4
17
30
KAY40
NOMESCO Finland
NA
0.5
6.4
65
1177
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
0.7
6.4
177
2556
G03GB02
ATC
clomifene; oral
1.7
6.4
126
755
SPAT1383
SPAT
Extensive health check-up at 4 years of age
1.9
6.3
87
465
M54.5
ICD-10 Finland
Low back pain
1.2
6.3
1358
11969
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
6.3
447
3481
TMW99
NOMESCO Finland
Other minor surgical procedure in obstetrics
1.9
6.3
80
414
O85
ICD-10 Finland
Puerperal sepsis
1.9
6.3
80
414
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
6.3
397
3043
O73.0
ICD-10 Finland
Retained placenta without haemorrhage
2.0
6.2
74
377
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.3
6.1
484
3827
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
12.5
6.1
10
8
W79
ICPC
Unwanted pregnancy
1.6
6.1
135
837
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
0.7
6.1
186
2637
O62.3
ICD-10 Finland
Precipitate labour
3.7
6.1
24
65
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
6.0
61
290
MBA96
NOMESCO Finland
Other removal of retained products of conception after delivery or abortion
1.6
6.0
152
974
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1051
4921
2.40
127.08
1.7
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
787
3662
2.34
94.36
1.6
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
1644
10198
1.87
89.81
1.6
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
879
4459
2.15
84.76
1.8
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
2379
17128
1.68
73.72
1.9
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
2124
14961
1.68
70.71
1.8
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
1039
6891
1.62
39.61
1.6
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3725
32184
1.48
38.62
4.4
3.7
e6/l
504.2
1312.9
1.69
39
332
(46235355) HIV 1 and 2 tests - Meaningful Use set
2530
20389
1.44
37.63
2.1
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1689
12651
1.48
36.64
3.7
3.3
estimate
0.0
0.0
0.10
736
4928
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
523
2925
1.87
36.49
3.4
3.7
u/l
227.4
226.4
0.06
499
2779
(40761536) Microorganisms panel - Urine sediment
707
4445
1.68
32.76
3.8
3.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
398
2149
1.92
30.81
2.4
2.2
umol/l
4.5
4.9
0.51
284
1582
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
1014
7053
1.54
30.60
2.8
2.2
u/l
8251.8
6129.3
1.21
498
2930
(3037467) Urinalysis macro (dipstick) panel - Urine
3763
33264
1.40
29.33
4.5
3.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2777
23512
1.36
27.30
4.4
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2828
24131
1.35
25.82
3.5
3.1
estimate
0.0
0.0
2.50
740
4901
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2288
18914
1.36
25.69
3.5
3.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2795
23889
1.34
24.83
3.5
3.0
estimate
0.0
0.0
1.15
721
4801
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
288
1503
1.97
24.61
1.7
1.6
mmol/l
7.3
7.6
1.43
171
918
(3026008) Bacteria identified in Urine by Culture
1601
12573
1.38
24.59
2.5
2.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2797
23972
1.33
24.07
4.6
4.2
estimate
0.0
0.0
0.02
749
4995
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
213
1027
2.12
22.63
3.3
2.0
g/l
1.1
1.3
1.90
190
893
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
194
908
2.18
22.24
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2218
18524
1.33
22.19
2.1
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
230
1155
2.03
21.92
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1150
8706
1.40
21.50
2.1
2.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
204
988
2.11
21.43
2.5
2.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
136
559
2.47
21.08
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1758
14396
1.32
19.51
3.1
2.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
121
509
2.41
17.89
1.2
1.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
37
73
5.10
17.85
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
176
870
2.06
17.57
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
207
1091
1.93
17.24
1.4
1.3
u/ml
107.4
106.6
0.06
57
265
(3019150) Specific gravity of Urine by Refractometry
1270
10141
1.33
16.27
3.6
3.2
kg/l
1.0
1.0
0.42
229
1541
(3028679) Herpes simplex virus Ab [Presence] in Serum
104
436
2.41
15.55
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1345
10952
1.30
14.73
4.3
4.0
inr
1.0
1.0
0.28
553
3929
(3023103) Potassium [Moles/volume] in Serum or Plasma
4660
44174
1.34
13.82
9.3
8.2
mmol/l
3.9
3.9
0.08
4540
42830
(3019550) Sodium [Moles/volume] in Serum or Plasma
4644
44048
1.33
13.35
9.2
8.1
mmol/l
139.3
139.5
6.30
4529
42842
(3013826) Glucose [Moles/volume] in Serum or Plasma
2542
22535
1.24
13.13
4.5
3.6
mmol/l
6.0
6.2
4.61
2181
19810
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
247
1495
1.68
13.04
3.0
2.4
g/l
3.9
3.6
2.04
229
1404
(3026493) Urate [Moles/volume] in Serum or Plasma
1108
8986
1.29
12.20
2.4
1.9
umol/l
960.6
2077.1
1.42
1010
8118
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2194
19270
1.23
12.01
4.9
4.8
umol/l
8.8
9.3
3.12
2052
18091
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
101
472
2.16
11.80
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
435
3097
1.44
11.09
2.8
2.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
226
1411
1.63
10.63
1.6
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
101
500
2.04
10.21
3.2
3.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3330
30764
1.20
10.11
6.6
6.2
u/l
71.3
69.9
1.12
3170
29060
(3000850) Epithelial cells [#/volume] in Urine
947
7718
1.27
9.82
2.5
2.2
e6/l
9.1
9.4
0.14
816
6632
(3044640) Blood type and Crossmatch panel - Blood
1678
14576
1.22
9.70
2.0
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1285
10863
1.24
9.66
2.2
2.1
mg/l
2.6
2.6
0.15
1126
9399
(3021589) Normoblasts [#/volume] in Blood
2254
20201
1.19
9.21
8.5
7.4
e9/l
0.0
0.0
0.54
1942
16653
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
34
106
3.22
9.01
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
405
2955
1.40
9.01
4.0
4.2
%
0.0
0.2
0.44
73
523
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
610
4744
1.32
9.00
1.6
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5224
50908
1.42
9.00
10.6
8.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1675
14637
1.21
8.95
4.6
4.0
g/l
36.6
37.2
4.39
1563
13705
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4933
47670
1.30
8.87
10.3
9.3
mg/l
17.6
17.8
0.14
3869
36389
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
354
2546
1.42
8.56
3.0
2.9
mmol/l
1.2
1.2
0.56
292
2217
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1419
12263
1.21
8.42
2.4
2.4
u/l
63.2
55.3
0.68
1342
11441
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
733
5908
1.28
8.23
1.5
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1071
9029
1.23
8.10
4.3
3.1
mmol/l
7.6
7.9
0.98
943
7929
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1066
8985
1.23
8.07
1.8
1.9
u/l
128.9
133.6
0.12
1017
8561
(3017181) Myelocytes/100 leukocytes in Blood
425
3185
1.36
8.04
3.9
4.1
%
1.1
0.8
0.42
86
663
(3021440) Promyelocytes/100 leukocytes in Blood
412
3073
1.37
8.04
4.0
4.2
%
0.2
0.2
0.05
80
623
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
196
1275
1.56
7.85
2.1
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3106
28857
1.17
7.72
3.3
3.0
ug/l
54.2
59.5
2.66
2932
27611
(4198724)
71
347
2.06
7.54
2.8
2.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
394
2951
1.36
7.50
3.9
3.9
%
0.8
0.5
0.55
66
494
(3026782) Osmolality of Urine
849
7050
1.24
7.34
2.8
2.3
mosm/kgh2o
524.4
530.2
0.28
727
5957
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
136
824
1.67
7.32
1.5
1.5
mmol/l
9.2
11.3
—
7
88
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1275
11037
1.20
7.28
2.3
2.2
ng/l
18.2
23.5
0.62
412
3647
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1611
14249
1.18
7.20
5.6
4.4
mmol/l
1.2
1.2
0.26
1473
13074
(3023511) Choriogonadotropin [Units/volume] in Urine
476
3689
1.32
7.20
1.4
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
5468
53952
1.73
7.12
15.7
14.0
pg
30.0
29.9
1.77
5443
53551
(3013707) Erythrocyte sedimentation rate by Westergren method
3539
33331
1.17
7.08
3.7
3.5
mm/h
9.0
8.8
0.46
3376
31512
(3000963) Hemoglobin [Mass/volume] in Blood
5470
53984
1.73
7.02
15.9
14.1
g/l
132.1
133.0
8.99
5444
53577
(3026361) Erythrocytes [#/volume] in Blood
5468
53961
1.72
6.99
15.8
14.0
e12/l
4.4
4.5
12.61
5401
53049
(3024731) MCV [Entitic volume]
5467
53955
1.71
6.90
15.7
14.0
fl
89.9
89.8
0.51
5442
53556
(3007461) Platelets [#/volume] in Blood
5463
53908
1.69
6.86
15.8
14.1
e9/l
268.0
270.6
2.43
5400
53029
(3010813) Leukocytes [#/volume] in Blood
5468
53977
1.70
6.76
15.8
14.1
e9/l
7.1
6.8
16.41
5398
53021
(3007853) Bacteria identified in Skin by Aerobe culture
620
5014
1.27
6.75
1.7
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
106
615
1.74
6.72
3.5
2.6
mmol/l
2.2
2.1
0.18
60
347
(3002582) Erythrocytes [#/volume] in Urine
1276
11128
1.19
6.63
3.0
2.6
e6/l
102.3
83.2
0.14
975
8203
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
241
1697
1.44
6.62
2.1
2.2
iu/l
53.5
4.1
0.49
109
745
(3018418) pH of Serum or Plasma
1105
9523
1.20
6.55
3.6
3.4
ph
7.4
7.4
0.07
258
1840
(3010421) pH of Blood
120
728
1.66
6.47
3.3
2.6
ph
7.4
7.4
2.05
102
609
(3018677) aPTT in Platelet poor plasma by Coagulation assay
567
4560
1.27
6.46
2.6
2.0
s
28.9
29.0
0.18
548
4397
(3037121) Protein [Mass/volume] in Urine
170
1124
1.53
6.40
3.2
2.9
g/l
0.3
0.3
0.00
77
466
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5036
49084
1.27
6.36
8.5
7.7
u/l
23.8
23.5
0.38
4904
47825
(3001019) Free T4 and TSH panel - Serum or Plasma
421
5370
0.77
6.34
1.7
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
220
1537
1.45
6.32
3.1
2.2
%
161.4
159.8
0.10
204
1441
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
539
6644
0.79
6.15
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
817
6880
1.22
6.13
4.8
4.0
mg/mmol
22.9
11.4
4.61
556
4487
(42870588) Differential panel, method unspecified - Blood
1564
13954
1.17
6.10
5.5
5.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
102
603
1.70
6.08
3.5
2.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
102
604
1.70
6.05
2.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
335
2533
1.34
6.04
1.2
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4402
42393
1.18
5.96
12.5
11.2
%
13.4
13.4
0.12
4311
41670
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1791
16169
1.16
5.95
6.1
5.0
mmol/l
1.2
1.2
0.87
1451
13707
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
371
4772
0.76
5.95
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
786
6621
1.22
5.87
4.0
3.4
mg/l
523.2
440.6
0.18
536
4218
(3037522) Nuclear Ab [Titer] in Serum
907
7747
1.20
5.87
1.4
1.4
titre
564.8
592.5
0.16
185
1542
(3023368) Bacteria identified in Blood by Culture
856
7274
1.21
5.85
3.7
3.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
672
5573
1.23
5.84
1.5
1.4
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
11
20
5.51
5.80
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
670
5560
1.23
5.79
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
668
5543
1.23
5.78
1.5
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
389
3028
1.31
5.73
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
671
5577
1.23
5.71
1.5
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1147
10033
1.18
5.66
3.0
2.5
e6/l
0.2
0.3
0.49
863
7264
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
129
831
1.57
5.51
1.6
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
694
8225
0.82
5.45
1.3
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
39
172
2.28
5.45
1.8
1.9
ml
1982.3
1920.9
0.13
34
164
(3028707) Methadone [Presence] in Urine by Screen method
233
1692
1.39
5.44
4.5
2.3
—
—
—
0
0
(3036489) Thrombin time
247
1812
1.38
5.43
2.5
1.9
s
20.6
20.5
0.00
199
1483
(36304419) Bacteria [Presence] in Urine
1159
10189
1.17
5.35
3.0
2.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
55
284
1.95
5.14
1.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1030
9000
1.18
5.11
1.7
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
53
272
1.96
5.05
1.2
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
67
373
1.81
4.99
1.2
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
89
545
1.64
4.74
2.4
2.0
%
17.3
17.1
0.15
48
262
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
372
2956
1.28
4.72
1.5
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
49
253
1.95
4.62
1.3
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
15
43
3.50
4.61
7.5
5.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
67
384
1.75
4.56
1.3
1.2
u/ml
2.5
12.4
—
6
45
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
216
1599
1.36
4.55
2.6
1.9
%
95.0
95.0
0.00
200
1445
(3011985) Renin [Units/volume] in Plasma
86
532
1.63
4.43
1.9
1.9
mu/l
33.7
48.4
1.28
74
491
(3042936) Bacteria identified in Isolate by Culture
586
4936
1.21
4.38
1.9
1.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
170
1218
1.41
4.37
1.7
1.5
mmol/l
6.1
6.7
2.53
125
875
(3014148) Varicella zoster virus Ab [Titer] in Serum
161
1144
1.42
4.34
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
56
3.04
4.23
1.1
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
225
1697
1.34
4.22
2.2
2.4
e9/l
67.2
72.3
1.38
165
1210
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
141
985
1.44
4.18
1.4
1.2
u/ml
5.6
3.9
0.60
64
397
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1112
9920
1.15
4.15
1.3
1.3
iu/ml
23.9
24.3
0.04
337
3017
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
560
4724
1.21
4.13
2.1
2.3
ng/l
655.3
369.8
0.59
442
3721
(3020356) Listeria sp identified in Specimen by Organism specific culture
24
97
2.48
4.12
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1344
12159
1.14
4.07
4.2
3.7
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
8
10
8.01
4.06
1.4
1.0
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
38
189
2.02
4.02
2.7
1.9
g/24h
2.0
1.6
—
5
20
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
77
476
1.63
4.01
1.2
1.1
ratio
1.0
1.0
0.01
27
179
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
124
853
1.46
4.00
3.6
3.0
mg/l
1.4
1.2
1.05
117
805
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
238
1829
1.31
3.95
3.0
2.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
143
1014
1.42
3.93
1.4
1.2
u/ml
4.6
3.0
0.38
51
349
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
25
106
2.36
3.89
2.8
2.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
37
186
2.00
3.82
3.8
2.5
%
10.3
11.0
0.53
37
186
(3005719) IgG [Mass/volume] in Serum or Plasma
402
3309
1.23
3.80
2.2
2.5
g/l
10.9
10.4
1.66
368
3067
(3033923) Metanephrine [Moles/time] in 24 hour Urine
17
60
2.84
3.78
1.1
1.1
umol/24h
0.7
0.6
—
9
36
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1869
17318
1.12
3.78
1.6
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
606
5198
1.19
3.73
2.4
2.1
g/l
2.5
2.5
0.04
561
4822
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
158
1154
1.38
3.69
1.1
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
59
349
1.70
3.67
2.0
1.7
%
100.3
101.2
0.08
50
312
(3006184) Hemoglobin [Mass/volume] in Capillary blood
99
666
1.50
3.61
2.5
2.0
g/l
131.2
131.5
0.04
86
506
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4074
41982
0.89
3.59
2.8
2.8
mmol/l
1.1
1.2
0.16
3890
40318
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1186
10726
1.13
3.57
2.0
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1197
10845
1.13
3.50
2.1
1.7
mg/l
1.1
0.8
3.04
885
7908
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
76
492
1.55
3.33
1.5
1.5
pmol/l
425.7
385.6
0.18
59
389
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1535
14157
1.12
3.29
1.3
1.3
u/ml
1.4
1.5
0.04
497
4237
(3042517) Benzodiazepines panel - Urine
25
115
2.18
3.28
2.2
2.5
—
—
—
0
0
(4268621)
100
689
1.46
3.27
2.5
2.2
—
—
—
0
0
(4034850)
175
1326
1.33
3.27
7.2
6.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2405
22713
1.10
3.26
5.5
5.6
e9/l
0.0
0.0
1.60
2178
20222
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1055
9523
1.13
3.26
1.3
1.3
u/ml
5.4
8.2
1.26
477
4160
(44790047)
58
355
1.64
3.21
1.4
1.4
—
—
—
0
0
(44790048)
58
355
1.64
3.21
1.4
1.4
—
—
—
0
0
(44790049)
58
355
1.64
3.21
1.4
1.4
—
—
—
0
0
(44806118)
58
355
1.64
3.21
1.4
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
17
394
0.43
3.20
13.8
12.3
nmol/l
599.4
857.4
1.51
17
381
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
60
371
1.62
3.20
1.0
1.1
miu/ml
1372.9
1472.8
0.32
60
371
(4306422)
136
997
1.37
3.16
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
96
663
1.46
3.12
1.4
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
97
673
1.45
3.08
1.4
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
181
1391
1.31
3.08
2.2
2.3
ng/l
112.9
78.1
0.60
156
1225
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
280
2272
1.24
3.08
1.5
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
914
8206
1.14
3.07
1.7
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2392
22633
1.10
3.06
5.5
5.5
e9/l
0.5
0.5
0.09
2174
20222
(3020779) Urea [Moles/volume] in Serum or Plasma
239
1907
1.26
3.04
9.7
7.0
mmol/l
6.6
6.5
0.16
231
1845
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4268
43753
0.90
3.03
3.0
3.1
mmol/l
1.5
1.5
0.09
4083
42017
(3044889) 12 lead EKG panel
2724
25949
1.10
3.00
2.6
2.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
43
248
1.74
2.98
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
128
943
1.37
2.91
1.1
1.1
%
120.7
117.3
0.65
116
859
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
43
250
1.73
2.91
2.0
1.8
iu/ml
493125.0
2579865.0
—
8
22
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
54
334
1.62
2.91
1.3
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4300
44037
0.90
2.90
12.8
11.6
g/l
332.5
332.2
1.30
4266
43713
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
53
329
1.62
2.82
1.1
1.1
%
87.0
91.1
0.49
41
272
(3022493) Free Hemoglobin [Mass/volume] in Plasma
25
123
2.04
2.81
4.5
3.0
mg/l
90.1
2886.2
0.78
20
90
(3017509) Phencyclidine [Presence] in Urine
22
103
2.14
2.80
2.5
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
556
4855
1.16
2.79
3.6
2.9
mmol/l
0.8
0.8
0.41
522
4570
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
46
277
1.67
2.76
1.1
1.1
%
102.2
101.3
0.05
22
112
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
47
286
1.65
2.72
1.1
1.1
%
98.1
98.4
0.02
22
115
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4323
44220
0.90
2.71
3.2
3.3
mmol/l
2.9
2.9
2.99
4094
42211
(3023183) Ammonium ion [Moles/volume] in Plasma
71
477
1.49
2.69
4.1
2.8
umol/l
30.4
31.9
0.25
57
420
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
47
287
1.64
2.68
1.1
1.1
%
114.7
120.4
0.52
39
257
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
153
1175
1.31
2.66
1.3
1.2
u/ml
278.8
252.5
0.61
111
798
(3003458) Phosphate [Moles/volume] in Serum or Plasma
403
3447
1.18
2.63
6.9
5.0
mmol/l
1.0
1.0
0.18
380
3260
(36660697) Celiac disease serology panel - Serum
563
4947
1.15
2.61
1.2
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4297
43943
0.90
2.60
3.0
3.1
mmol/l
4.8
4.8
2.35
4105
42251
(3014576) Chloride [Moles/volume] in Serum or Plasma
347
2934
1.19
2.58
10.3
6.0
mmol/l
104.9
105.1
0.34
342
2883
(3006504) Eosinophils/100 leukocytes in Blood
2243
21281
1.09
2.57
5.5
5.5
%
2.8
2.7
0.69
2105
19962
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
17
74
2.30
2.57
1.1
1.2
mg/l
0.5
100.5
0.71
12
49
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4608
45158
1.12
2.56
4.2
4.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
149
1147
1.31
2.56
12.9
8.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
103
751
1.38
2.54
1.5
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
251
2061
1.23
2.53
10.8
6.0
mmol/l
1.3
1.2
0.10
244
1992
(3000991) Gas panel - Venous blood
233
1899
1.24
2.52
12.7
7.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2692
25757
1.09
2.52
7.2
7.9
e9/l
4.2
4.0
4.13
2431
22838
(40768446) Kidney Pathology biopsy report
25
129
1.94
2.49
2.4
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
241
1975
1.23
2.48
11.6
7.3
g/l
118.5
121.8
1.73
229
1894
(3008898) HLA-B27 [Presence]
356
3031
1.19
2.47
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
1158
10671
1.11
2.46
1.9
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
590
5230
1.14
2.42
2.4
2.5
ng/l
179.5
321.3
0.82
250
2209
(3019069) Monocytes/100 leukocytes in Blood
2253
21424
1.09
2.41
5.7
5.7
%
7.6
7.7
1.64
2137
20289
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
519
4565
1.15
2.39
2.6
2.2
%
24.7
24.2
0.38
426
3960
(3018095) Leukocytes [#/volume] in Urine
1560
14609
1.09
2.37
3.5
3.0
e6/l
82.8
64.6
0.52
1070
9134
(3013115) Eosinophils [#/volume] in Blood
2473
23619
1.08
2.37
5.6
5.7
e9/l
0.2
0.2
1.95
2269
21424
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
183
1464
1.26
2.36
1.5
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
12
46
2.61
2.35
1.8
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
298
2510
1.20
2.34
1.5
1.8
g/l
1.4
1.4
0.40
276
2350
(3011397) Hemoglobin [Presence] in Urine by Test strip
1145
10578
1.10
2.31
3.5
3.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1626
15272
1.09
2.30
2.9
2.9
u/l
29.1
28.0
0.50
1551
14640
(3015171) Extractable nuclear Ab [Units/volume] in Serum
292
2460
1.20
2.30
1.3
1.3
u/ml
0.4
1.1
1.14
27
200
(3003888) Timothy IgE Ab [Units/volume] in Serum
127
1643
0.77
2.30
1.1
1.1
u/ml
5.4
5.6
0.03
66
877
(3014007) Fractional oxyhemoglobin in Arterial blood
161
1273
1.27
2.29
14.8
8.1
%
94.0
94.5
0.31
161
1266
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
239
2870
0.83
2.24
1.4
1.6
mg/l
3.8
3.6
0.07
152
1917
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
54
358
1.51
2.24
1.6
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
2153
20483
1.08
2.23
5.6
5.6
%
0.7
0.7
0.77
2028
19210
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
9
5.56
2.21
5.0
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
157
1244
1.27
2.21
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1844
19464
0.92
2.20
2.0
2.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
650
5839
1.13
2.19
2.4
2.1
umol/l
14.5
14.8
0.47
609
5431
(3003181) Sodium [Moles/volume] in Urine
45
288
1.57
2.18
1.8
1.5
mmol/l
66.8
67.0
0.01
40
235
(3041806) Other cells [#/volume] in Blood by Manual count
31
514
0.60
2.16
1.5
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
159
1266
1.26
2.16
14.8
8.1
%
1.5
1.4
0.57
159
1257
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
144
1133
1.28
2.15
5.7
4.0
mmol/l
23.8
24.1
0.61
123
1014
(3011288) Drugs identified in Urine by Screen method
322
2754
1.18
2.15
6.3
2.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
16
74
2.17
2.14
1.6
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2471
23673
1.08
2.11
5.5
5.5
e9/l
2.0
2.0
0.31
2271
21563
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
24
132
1.82
2.03
1.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
303
2593
1.18
2.03
2.4
2.5
%
1.6
1.7
0.10
275
2301
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
12
50
2.40
2.02
6.0
5.2
ug/min
35.6
23.0
—
7
32
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
27
155
1.75
1.99
1.0
1.1
%
21.0
1.9
—
7
14
(3016502) Oxygen saturation in Arterial blood
244
2055
1.20
1.97
11.3
7.1
%
96.7
96.5
0.13
233
1960
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
158
1273
1.25
1.97
15.0
8.1
%
0.7
0.7
0.02
158
1266
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
51
345
1.48
1.96
1.4
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
114
884
1.30
1.94
3.9
4.8
mmol/l
1.1
1.2
2.25
99
774
(1001926) Buprenorphine [Presence] in Urine by Screen method
351
3053
1.16
1.93
3.8
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
135
1071
1.27
1.92
1.6
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
43
283
1.52
1.89
1.1
1.3
%
61.8
68.5
—
8
24
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
320
3686
0.86
1.89
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
519
4647
1.13
1.87
1.6
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50
341
1.47
1.86
1.4
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
46
2.39
1.85
1.2
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
122
1536
0.79
1.84
1.1
1.1
u/ml
0.4
1.0
2.97
47
638
(3019230) Fractional oxyhemoglobin in Venous blood
56
392
1.43
1.83
7.1
3.7
%
62.7
63.3
0.07
56
392
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4628
45547
1.10
1.80
5.2
4.9
mu/l
1.6
1.9
3.29
4424
43662
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
35
2.57
1.80
1.1
1.1
umol/24h
1.4
1.4
—
9
35
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3349
34411
0.93
1.79
2.7
2.6
u/l
32.9
30.4
1.60
3212
33182
(3027801) Oxygen [Partial pressure] in Arterial blood
280
2410
1.17
1.78
10.6
6.5
kpa
14.5
14.3
0.16
265
2306
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
280
2410
1.17
1.78
10.6
6.5
kpa
5.0
5.0
0.24
266
2307
(3015377) Calcium [Moles/volume] in Serum or Plasma
1277
11993
1.08
1.78
2.9
2.8
mmol/l
2.3
2.3
1.06
1178
10906
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
47
2.34
1.77
2.0
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
123
977
1.26
1.76
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
197
1648
1.20
1.75
1.8
1.6
iu/ml
0.3
10.9
0.50
30
316
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
34
217
1.57
1.73
1.8
2.8
umol/l
119.6
176.4
0.57
13
118
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
35
225
1.56
1.72
1.1
1.1
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
13
3.85
1.71
1.0
1.1
%
29.4
34.6
—
5
13
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
59
423
1.40
1.71
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
27
163
1.66
1.71
1.2
1.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
35
226
1.55
1.70
1.8
2.0
mg/l
9.1
9.8
0.31
28
181
(3019060) Gas panel - Arterial blood
156
1280
1.23
1.69
5.3
4.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
151
1836
0.82
1.68
1.1
1.1
u/ml
3.0
1.1
0.84
54
700
(3003396) Base excess in Arterial blood by calculation
280
2424
1.16
1.67
10.6
6.6
mmol/l
0.4
0.6
0.47
203
1770
(3034426) Prothrombin time (PT)
32
203
1.58
1.67
1.4
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
95
736
1.30
1.67
2.8
2.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
68
502
1.36
1.66
4.4
3.6
u/ml
0.3
0.4
0.54
35
271
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
342
1.44
1.65
2.1
1.5
promille
1.2
1.3
0.30
33
259
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4163
40834
1.08
1.65
4.7
4.4
pmol/l
14.2
14.2
0.06
3947
38689
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
39
260
1.50
1.65
1.5
1.4
u/l
5.4
5.2
0.10
32
225
(3006462) Nitrate [Presence] in Urine
35
228
1.54
1.64
2.9
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
587
5338
1.11
1.64
1.2
1.2
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
15
76
1.98
1.64
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
171
1423
1.21
1.62
1.7
1.7
ug/l
4.3
4.6
0.10
157
1234
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
95
740
1.29
1.62
2.4
2.1
ug/l
148.4
243.8
0.75
82
631
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
14
3.57
1.61
1.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
26
2.69
1.58
20.3
7.8
mmol/l
5.0
5.4
—
7
26
(3000492) Spirometry study
423
4716
0.89
1.57
1.4
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
543
4934
1.11
1.55
1.8
1.6
nmol/l
1256.1
1189.1
0.75
441
3968
(3022621) pH of Urine by Test strip
330
2913
1.14
1.53
3.2
2.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
204
1738
1.18
1.51
2.9
2.0
g/l
0.2
0.2
1.59
194
1656
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
41
282
1.46
1.51
1.5
1.6
nmol/l
1.5
1.5
0.07
36
255
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
44
0.00
1.51
0.0
1.1
—
3.4
—
0
6
(3005033) Fetal Nuchal fold Thickness US
500
4533
1.11
1.50
1.5
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
197
1677
1.18
1.48
1.5
2.1
g/l
67.9
67.8
0.07
181
1570
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
204
0.49
1.48
1.9
1.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
278
2432
1.15
1.48
1.1
1.1
u/ml
1.6
10.1
—
8
27
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
26
163
1.60
1.46
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
27
171
1.58
1.45
1.5
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
462
4181
1.11
1.44
1.3
1.3
u/ml
159.7
194.6
0.48
426
3890
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
48
344
1.40
1.44
1.9
1.7
mg/l
20.5
25.0
0.37
17
93
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
16
3.13
1.44
2.4
4.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
500
4545
1.11
1.44
1.5
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
600
5505
1.10
1.43
2.1
2.3
mmol/l
2.4
2.4
0.23
523
4767
(3002032) Base excess in Venous blood by calculation
234
2027
1.16
1.43
4.8
3.6
mmol/l
1.6
1.6
0.11
189
1607
(40761535) Cells panel - Urine sediment
304
2686
1.14
1.41
3.6
3.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
18
103
1.75
1.40
6.9
4.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
474
4306
1.11
1.38
4.0
3.4
pmol/l
4.6
4.6
0.94
430
3883
(3023430) Cat dander IgE Ab [Units/volume] in Serum
104
1283
0.81
1.38
1.1
1.1
u/ml
3.9
4.7
0.18
43
525
(3041354) Potassium [Moles/volume] in Venous blood
11
211
0.52
1.37
1.8
1.9
mmol/l
3.8
3.9
0.05
11
211
(3004119) Hemoglobin [Mass/volume] in Venous blood
156
1312
1.19
1.37
4.5
3.3
g/l
128.0
131.3
1.08
149
1280
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
794
7395
1.09
1.37
1.6
1.5
pmol/l
87161620.7
29479227.8
1.08
701
6581
(40759836) Histone Ab [Presence] in Serum by Immunoblot
61
460
1.33
1.35
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
232
2020
1.15
1.34
1.1
1.1
u/ml
8.4
4.5
0.63
30
346
(3048929) Epstein Barr virus Ab [Presence] in Serum
273
2405
1.14
1.34
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
61
461
1.33
1.34
1.2
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2297
22200
1.06
1.34
5.4
5.3
%
56.9
56.5
1.33
2176
21028
(3002030) Lymphocytes/100 leukocytes in Blood
2326
22489
1.06
1.33
5.5
5.5
%
29.5
30.1
1.94
2199
21258
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
61
462
1.32
1.32
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
271
0.59
1.32
1.0
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
207
1791
1.16
1.31
2.9
1.9
g/l
1.1
1.2
1.23
196
1711
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
88
1097
0.80
1.30
1.0
1.1
u/ml
0.0
0.3
1.03
14
214
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
257
0.58
1.29
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
18
294
0.61
1.29
1.3
1.2
—
—
—
0
0
(4146454)
9
172
0.52
1.28
3.8
2.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
96
1183
0.81
1.28
1.8
2.1
mg/l
10.0
10.0
0.00
90
1123
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
18
2.78
1.28
1.2
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
18
2.78
1.28
1.2
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
69
1.89
1.28
1.8
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
19
114
1.67
1.28
1.1
1.5
—
1508.3
—
0
9
(3039000) Anion gap in Blood
65
500
1.30
1.27
5.1
6.7
mmol/l
10.8
11.1
0.43
57
442
(3004588) Protein electrophoresis panel - Serum or Plasma
145
1222
1.19
1.27
1.5
1.8
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
65
501
1.30
1.26
5.1
6.7
mmol/l
105.4
105.7
0.17
57
443
(3010726) Horse dander IgE Ab [Units/volume] in Serum
132
1572
0.84
1.26
1.1
1.1
u/ml
1.0
1.6
0.96
28
381
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
38
269
1.42
1.25
1.7
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
931
9884
0.93
1.25
1.4
1.5
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
25
2.40
1.24
1.2
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
25
2.40
1.24
1.0
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
139
1170
1.19
1.24
1.3
1.3
u/ml
1.3
3.6
—
10
94
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
241
0.58
1.24
1.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
155
1318
1.18
1.23
7.6
6.4
mmol/l
24.0
24.1
0.14
142
1222
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
61
468
1.31
1.23
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
61
468
1.31
1.23
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
54
408
1.33
1.21
1.7
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
31
213
1.46
1.20
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
61
470
1.30
1.20
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
104
855
1.22
1.19
5.6
4.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
483
4433
1.10
1.18
2.5
2.3
umol/l
5.4
5.5
0.05
382
3682
(3021447) Carbon dioxide [Partial pressure] in Venous blood
233
2052
1.14
1.18
4.8
3.6
kpa
5.9
5.8
0.22
223
1979
(3044927) Protein electrophoresis panel - Urine
19
117
1.63
1.17
1.0
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
11
57
1.93
1.17
1.3
1.4
%
60.5
44.7
—
6
36
(3035285) Chloride [Moles/volume] in Venous blood
12
211
0.57
1.16
1.8
1.9
mmol/l
105.3
106.0
0.30
12
211
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1475
14126
1.06
1.16
2.1
2.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
31
439
0.70
1.15
2.0
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
110
1319
0.83
1.15
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
110
1319
0.83
1.15
1.1
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1742
16772
1.06
1.13
1.8
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
80
644
1.25
1.12
1.4
1.5
—
—
—
0
0
(4211845)
35
250
1.40
1.12
2.9
2.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
8
40
2.00
1.12
6.0
7.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
47
353
1.33
1.11
1.4
1.3
u/ml
2.3
9.4
—
6
29
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
231
2045
1.14
1.10
1.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
63
495
1.28
1.09
1.4
1.4
—
—
—
0
0
(3025315) Body weight
5
21
2.38
1.09
5.0
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
62
487
1.28
1.08
6.6
3.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
51
391
1.31
1.06
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
355
3895
0.91
1.06
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
67
533
1.26
1.06
1.2
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
204
2310
0.88
1.05
1.8
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
418
1.29
1.05
2.3
2.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
28
195
1.44
1.04
2.1
1.9
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
15
90
1.67
1.03
1.4
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
46
1.96
1.03
1.6
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
60
1.83
1.02
3.6
3.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
29
204
1.42
1.02
1.4
1.7
mg/l
2.2
2.7
1.12
29
194
(3044941) Cell count panel - Synovial fluid
53
412
1.29
1.01
1.3
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
197
2228
0.88
1.01
1.6
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
34
247
1.38
1.01
1.8
1.8
u/field
1.4
2.3
1.15
22
134
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
154
1336
1.16
1.00
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
167
1458
1.15
1.00
1.9
2.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
35
2.00
1.00
1.1
2.9
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
117
1373
0.85
0.99
1.0
1.1
u/ml
5.1
4.9
0.04
47
528
(3025468) Yersinia sp identified in Specimen by Organism specific culture
59
467
1.27
0.98
1.1
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
60
476
1.26
0.98
1.1
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
192
1695
1.14
0.98
1.3
1.3
u/ml
45.0
32.3
0.23
12
131
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
23
2.17
0.98
1.0
1.0
u/l
5.2
17.2
—
5
23
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
14
84
1.67
0.97
1.0
1.0
u/ml
0.1
0.5
—
7
47
(3005988) Vibrio sp identified in Specimen by Organism specific culture
59
468
1.26
0.97
1.1
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
613
5740
1.08
0.97
2.5
2.2
e6/l
1.1
1.2
0.32
352
3035
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
61
486
1.26
0.97
1.1
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
30
215
1.40
0.97
1.4
1.5
e6/l
79761.4
6354.9
0.48
19
147
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
101
1196
0.84
0.96
1.1
1.1
u/ml
4.6
2.9
0.31
47
686
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
141
1625
0.86
0.96
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
33
241
1.37
0.96
1.8
2.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
59
469
1.26
0.96
1.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
130
1507
0.86
0.96
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
394
3627
1.09
0.95
3.7
1.9
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
366
3359
1.10
0.94
1.1
1.1
titre
510.8
202.2
0.52
12
89
(3039162) Centromere protein B Ab [Units/volume] in Serum
91
760
1.20
0.94
1.3
1.3
u/ml
68.0
50.8
—
5
55
(3004451) EKG impression Narrative
11
62
1.78
0.94
1.4
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
116
0.52
0.94
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
116
0.52
0.94
1.3
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
120
0.50
0.93
1.2
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
47
600
0.78
0.92
3.1
3.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
12
70
1.72
0.92
1.5
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
114
974
1.17
0.92
4.6
3.2
%
0.6
0.7
0.54
108
941
(3025941) Bacteria identified in Stool by Culture
310
3390
0.91
0.90
1.3
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
77
637
1.21
0.89
1.2
1.1
—
1.1
—
0
5
(3015076) Soybean IgE Ab [Units/volume] in Serum
43
551
0.78
0.88
1.1
1.0
u/ml
0.1
0.3
—
8
70
(3024522) Salmonella sp identified in Specimen by Organism specific culture
59
475
1.24
0.88
1.1
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
25
178
1.41
0.86
1.8
1.7
au/ml
67.0
166.3
—
5
24
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
54
432
1.25
0.85
1.9
2.0
u/ml
24.0
5.8
0.67
41
339
(3000475) Leukocytes [#/volume] in Synovial fluid
72
595
1.21
0.85
1.7
1.7
e6/l
12398.1
7875.4
0.31
55
434
(3051611) Lipemic interference index of Serum or Plasma
38
291
1.31
0.84
2.5
2.6
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
10
57
1.76
0.83
1.0
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
86
725
1.19
0.83
7.1
5.0
iu/ml
340.7
483.8
0.37
11
71
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
11
65
1.69
0.82
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
94
800
1.18
0.82
1.1
1.1
iu/ml
69.1
12366.5
0.64
33
217
(3045414) Leukocytes [Presence] in Urine
230
2081
1.11
0.82
1.8
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
59
480
1.23
0.82
1.2
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
32
1.88
0.81
1.2
1.5
%
30.8
62.6
—
6
27
(3004616) Nuclear Ab [Presence] in Serum
75
626
1.20
0.81
1.5
1.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
14
89
1.57
0.81
1.0
1.0
u/ml
0.0
0.0
—
7
51
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
89
1.57
0.81
2.1
3.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
58
472
1.23
0.80
1.2
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
436
1.24
0.80
1.6
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
41
320
1.28
0.80
1.8
1.7
%
41.8
46.6
0.28
23
190
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
29
215
1.35
0.80
1.5
1.5
u/field
5.2
1.9
0.46
24
152
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
123
1072
1.15
0.80
16.3
8.2
mmol/l
23.7
23.9
0.40
117
1018
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
138
1214
1.14
0.79
1.1
1.3
titre
65.8
113.9
1.05
12
123
(3051101) Glucose [Moles/volume] in Cord blood
0
25
0.00
0.79
0.0
2.6
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
25
0.00
0.79
0.0
3.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
423
3944
1.08
0.79
1.5
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
41
321
1.28
0.79
1.2
1.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.4
—
24.9
—
0
27
(3029075) Extractable nuclear Ab panel - Serum
23
165
1.40
0.77
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
181
1623
1.12
0.77
4.1
3.1
kpa
4.5
4.7
0.90
175
1561
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
28
208
1.35
0.77
3.9
2.9
%
43.4
45.3
—
9
78
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
50
403
1.24
0.76
1.0
1.1
u/l
1.0
1.0
0.10
17
153
(3020650) Glucose [Presence] in Urine
22
157
1.40
0.76
1.2
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
834
7963
1.06
0.75
2.7
2.4
ug/g
95.4
92.7
0.10
667
6218
(3033658) Prothrombin time (PT) actual/Normal
997
9565
1.05
0.75
3.6
3.1
%
100.0
99.5
0.31
949
9247
(3000093) Morphology [Interpretation] in Blood Narrative
32
244
1.31
0.75
1.3
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
101
873
1.16
0.75
3.9
4.7
%
2.1
1.8
1.08
92
809
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4229
41831
1.05
0.74
8.3
7.4
ml/min/173m2
96.6
96.1
0.84
3475
33812
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
33
253
1.31
0.74
3.2
3.1
mg/l
7.7
7.9
0.06
26
192
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
57
468
1.22
0.74
1.2
1.2
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
7
38
1.84
0.73
1.1
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
14
207
0.68
0.72
2.2
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
190
1718
1.11
0.71
1.9
2.3
e6/l
0.2
0.2
0.45
177
1623
(3024869) Neuronal Ab [Presence] in Serum
7
40
1.75
0.71
1.1
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
295
2726
1.09
0.70
2.5
2.2
g/l
0.2
0.2
0.41
270
2581
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
72
609
1.18
0.70
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7
41
1.71
0.70
1.0
1.2
—
1.4
—
0
9
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
169
0.65
0.68
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
90
778
1.16
0.68
1.1
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
16
110
1.46
0.68
1.3
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
221
2414
0.91
0.68
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
156
0.64
0.67
1.1
1.0
—
—
—
0
0
(4035726)
301
2792
1.08
0.67
1.3
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
35
276
1.27
0.66
1.2
1.7
nmol/l
1.7
2.0
0.19
26
217
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4221
41788
1.04
0.66
3.0
3.1
mmol/l
5.4
5.5
6.11
3983
39599
(3007164) IgA [Mass/volume] in Serum or Plasma
1221
11812
1.04
0.66
1.4
1.4
g/l
2.1
2.1
0.35
806
7739
(3021387) Prolactin [Units/volume] in Serum or Plasma
479
4522
1.06
0.66
1.6
1.6
mu/l
301.9
310.0
0.16
413
4023
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
371
3961
0.93
0.66
2.5
2.8
%
33.3
32.7
0.59
308
3089
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
100
875
1.15
0.65
1.2
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
11
70
1.57
0.65
1.4
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
236
0.72
0.64
1.3
1.6
—
—
—
0
0
(3013512) EKG study
836
8025
1.05
0.64
2.4
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
167
1512
1.11
0.63
2.1
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
751
7194
1.05
0.62
1.5
1.4
nmol/l
18.9
20.9
4.67
685
6507
(3005082) Progesterone [Moles/volume] in Serum or Plasma
125
1115
1.12
0.62
1.3
1.4
nmol/l
29.1
32.0
0.61
114
1025
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
166
1505
1.11
0.62
1.4
1.3
u/ml
4.0
6.6
0.44
18
166
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
56
470
1.19
0.62
1.4
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
103
0.58
0.62
1.2
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3642
36859
0.97
0.62
3.5
3.7
mmol/mol
36.2
36.7
3.61
3455
35194
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
5
30
1.67
0.61
1.4
1.2
ug/g
142.8
177.9
—
5
25
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
27
346
0.78
0.61
5.1
7.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
21
0.00
0.60
0.0
1.1
—
102.0
—
0
21
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
621
5929
1.05
0.59
1.3
1.2
iu/ml
162.3
150.7
0.31
260
2372
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
39
317
1.23
0.59
1.3
1.2
u/l
49.7
59.4
0.53
24
212
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
22
0.00
0.59
0.0
3.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
34
272
1.25
0.59
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
147
1622
0.90
0.58
3.2
2.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
81
706
1.15
0.58
1.7
2.0
ug/l
2.8
1.2
0.51
63
631
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
26
332
0.78
0.58
1.2
1.3
—
90.0
—
0
6
(3007930) Methemoglobin/Hemoglobin.total in Blood
98
866
1.13
0.58
4.0
4.9
%
0.9
0.9
0.21
89
804
(3005011) Chlamydia sp Ab [Titer] in Serum
13
89
1.46
0.58
1.4
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
167
1830
0.91
0.57
1.9
2.1
u/l
38.0
38.9
0.27
161
1730
(3000764) Benzodiazepines [Presence] in Urine
419
3961
1.06
0.57
3.6
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
44
364
1.21
0.57
1.5
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
193
1.30
0.57
1.6
1.7
u/l
7.7
3.8
—
9
102
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
26
202
1.29
0.57
1.5
1.4
pmol/l
12.9
13.3
0.32
21
172
(4010399)
264
2458
1.08
0.56
1.4
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
145
1314
1.11
0.56
1.9
1.9
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
54
457
1.18
0.56
1.2
1.1
—
71.4
—
0
9
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
11
73
1.51
0.56
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
90
0.56
0.55
1.4
1.6
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
37
1.62
0.55
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
214
2313
0.92
0.55
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
105
936
1.12
0.55
1.4
1.3
ug/g
317.6
327.6
0.17
50
449
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
31
248
1.25
0.55
1.9
1.6
%
47.1
43.6
0.16
20
138
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
362
0.80
0.54
3.1
2.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
14
99
1.42
0.54
1.9
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1620
15823
1.03
0.53
2.2
2.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
47
395
1.19
0.53
1.0
1.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
21
160
1.31
0.53
1.1
1.1
u/ml
0.1
1.3
1.12
16
114
(3023420) DNA double strand Ab [Units/volume] in Serum
73
637
1.15
0.53
2.0
1.8
iu/ml
26.6
33.7
—
5
40
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
215
1993
1.08
0.52
4.7
3.3
ng/l
79.3
74.3
0.34
195
1800
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
35
286
1.23
0.52
1.1
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
421
3995
1.06
0.52
3.7
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
143
1.33
0.52
1.4
2.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
97
0.62
0.52
1.0
2.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
99
1107
0.89
0.52
1.3
1.3
nmol/l
1.2
1.4
1.63
80
924
(3045683) HLA typing for celiac disease panel - Blood or Tissue
43
511
0.84
0.51
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
64
1.41
0.51
1.3
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
64
1.41
0.51
1.4
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
75
1.47
0.50
1.7
1.3
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
13
92
1.41
0.50
1.0
1.0
u/ml
0.2
0.1
—
6
50
(4015189)
6
41
1.46
0.50
2.0
3.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
83
735
1.13
0.50
5.7
3.6
mmol/l
1.3
1.3
0.06
83
722
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
65
566
1.15
0.49
2.0
1.9
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
17
127
1.34
0.49
2.6
2.9
ng/l
57.7
105.0
0.72
12
73
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
167
0.72
0.49
1.2
1.1
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
15
110
1.36
0.48
1.0
1.0
u/ml
0.0
0.1
—
9
65
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
152
1396
1.09
0.48
1.2
1.3
u/ml
55.0
37.4
0.61
11
139
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
56
484
1.16
0.47
1.5
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
56
645
0.87
0.47
1.0
1.1
—
46.5
—
0
5
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
166
1532
1.09
0.47
1.4
1.3
u/ml
3.4
9.6
2.84
25
267
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
56
644
0.87
0.46
1.0
1.1
—
24.5
—
0
6
(3014765) Yersinia sp identified in Stool by Organism specific culture
139
1515
0.92
0.46
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
418
3985
1.05
0.46
3.6
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
137
1493
0.92
0.45
1.1
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
8
118
0.68
0.45
1.4
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
32
385
0.83
0.45
1.7
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
87
969
0.90
0.45
3.5
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
461
4816
0.95
0.44
1.9
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
92
828
1.11
0.44
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
51
1.37
0.44
1.1
1.2
ng/l
99.9
81.8
—
7
51
(42529406) Shigella sp [Presence] in Stool by Culture
140
1520
0.92
0.43
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
594
5721
1.04
0.43
1.5
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
983
9560
1.03
0.43
1.5
1.6
mmol/l
1.3
1.3
0.36
852
8504
(3024932) HLA-DR beta [Type]
14
104
1.35
0.43
1.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
32
1.56
0.42
1.8
1.6
umol/24h
216.2
314.5
—
5
32
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
94
0.64
0.42
1.2
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
25
203
1.23
0.42
1.1
1.3
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
18
140
1.29
0.41
1.6
1.5
%
2.8
5.6
—
5
29
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
680
1.12
0.41
1.7
1.8
g/l
2.9
3.0
0.61
61
534
(3049242) von Willebrand panel - Platelet poor plasma
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
37
314
1.18
0.41
1.6
3.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
15
114
1.32
0.40
1.1
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
109
996
1.10
0.40
2.9
3.0
mmol/l
25.4
25.2
0.34
103
952
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
705
6827
1.04
0.40
2.0
1.6
%
1.4
1.3
5.11
625
6217
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
102
0.69
0.39
1.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
35
1.43
0.39
1.2
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
26
214
1.22
0.39
1.3
1.6
nmol/l
128.2
125.1
0.14
26
214
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
19
0.00
0.39
0.0
5.9
—
63.9
—
0
11
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
106
0.66
0.39
1.3
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
30
251
1.20
0.39
1.1
1.1
u/ml
0.2
3.2
2.39
18
142
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
150
1394
1.08
0.38
1.5
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
64
570
1.12
0.38
1.9
1.7
g/l
0.0
0.0
1.02
58
535
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
25
206
1.21
0.37
1.9
2.2
ug/l
0.8
1.2
1.25
25
194
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
70
628
1.12
0.37
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
70
628
1.12
0.37
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
49
557
0.88
0.37
1.3
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
14
107
1.31
0.37
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
629
1.11
0.37
1.8
1.8
g/l
10.7
10.4
0.24
60
552
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
17
134
1.27
0.36
2.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
562
5436
1.04
0.35
2.6
2.3
e6/l
5.6
5.0
0.38
298
2742
(3008757) Leukocyte morphology finding [Identifier] in Blood
31
263
1.18
0.35
2.3
2.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
29
342
0.85
0.35
1.3
1.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
5
79
0.63
0.35
1.8
1.5
u/l
5.7
53.0
—
5
66
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
203
1916
1.06
0.35
1.3
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
52
585
0.89
0.34
1.1
1.0
u/ml
0.5
0.9
0.87
15
136
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
54
606
0.89
0.34
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
10
73
1.37
0.34
1.2
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
6
44
1.36
0.34
1.5
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
355
3700
0.96
0.34
2.2
2.3
u/l
46.6
35.1
1.36
288
3157
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
182
1714
1.06
0.34
1.2
1.2
—
—
—
0
0
(4281824)
46
521
0.88
0.34
1.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
29
246
1.18
0.34
2.7
2.5
au/ml
175.7
161.7
—
6
37
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
60
538
1.12
0.33
2.7
2.6
—
—
—
0
0
(3009343) pH of Capillary blood
154
1443
1.07
0.33
2.9
2.4
ph
7.4
7.4
0.03
36
209
(3034092) Cytoplasmic Ig cells/100 cells in Blood
12
91
1.32
0.33
5.0
5.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
230
2183
1.06
0.33
1.6
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
128
1374
0.93
0.33
1.3
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
55
615
0.89
0.33
1.1
1.2
nmol/l
56.8
56.9
0.01
55
608
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
136
1.25
0.33
1.0
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
156
1463
1.07
0.33
2.9
2.5
kpa
5.0
5.1
0.56
151
1364
(3013139) Helicobacter pylori Ag [Presence] in Stool
330
3442
0.96
0.33
1.2
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
27
228
1.19
0.33
1.1
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
56
501
1.12
0.33
1.7
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
89
0.67
0.33
1.2
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
17
209
0.81
0.32
2.1
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
105
972
1.08
0.32
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
108
1001
1.08
0.32
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
41
361
1.14
0.31
1.8
4.6
mmol/l
6.2
6.9
0.48
31
299
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
149
1401
1.07
0.30
3.0
2.4
mmol/l
0.7
1.1
0.88
102
941
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
99
0.71
0.30
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
99
0.71
0.30
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
99
0.71
0.30
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
99
0.71
0.30
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
30
347
0.86
0.30
1.1
1.1
nmol/l
409.1
420.9
0.14
30
335
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
75
1.33
0.30
1.5
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
385
3714
1.04
0.30
1.6
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
11
84
1.31
0.30
3.1
2.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
165
1746
0.94
0.30
1.8
1.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
53
477
1.11
0.29
1.2
1.2
u/ml
0.1
1.0
0.96
22
165
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
67
611
1.10
0.29
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
139
1.22
0.29
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
110
0.73
0.28
1.3
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
110
0.73
0.28
1.3
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
351
3639
0.96
0.28
4.4
4.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
407
3937
1.04
0.28
3.3
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
699
1.09
0.28
1.7
1.8
g/l
3.3
3.7
2.83
55
512
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
699
1.09
0.28
1.7
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
140
1319
1.06
0.28
2.2
2.2
%
13.2
13.1
0.61
140
1303
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
76
1.32
0.28
1.5
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
35
308
1.14
0.27
1.1
1.1
u/ml
4.5
8.9
—
7
61
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
76
700
1.09
0.27
1.7
1.8
g/l
6.7
7.1
2.02
62
550
(3007916) DNA double strand Ab [Titer] in Serum
8
64
1.25
0.27
1.3
1.5
—
210.4
—
0
10
(3013166) Neutrophils/100 leukocytes in Synovial fluid
8
64
1.25
0.27
1.5
1.5
%
24.8
37.0
—
8
53
(3034860) Kappa light chains.free [Mass/volume] in Serum
46
413
1.11
0.27
2.0
3.1
mg/l
31.0
40.6
0.44
36
343
(3022145) Colonoscopy Study observation
450
4365
1.03
0.27
1.3
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
26
224
1.16
0.27
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
285
2741
1.04
0.27
2.4
2.1
—
—
—
0
0
(3000012) Reticulocyte production index
15
122
1.23
0.27
1.5
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
28
243
1.15
0.26
2.5
2.9
mg/l
73.4
83.3
0.08
21
169
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
128
0.78
0.26
1.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
10
128
0.78
0.26
1.0
1.0
ug/l
64.3
71.3
—
10
116
(4027681)
54
490
1.10
0.26
1.4
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
255
2656
0.96
0.26
1.2
1.3
ug/l
3.1
3.4
0.62
232
2495
(3000060) B lymphocytes [#/volume] in Blood
16
193
0.83
0.26
2.8
2.3
e6/l
290.0
186.3
—
7
115
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
121
1139
1.06
0.26
1.2
1.3
e6/l
31.9
18.4
0.53
97
891
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
383
0.89
0.25
2.7
2.3
%
10.9
12.6
0.39
19
223
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
14
114
1.23
0.25
1.6
1.6
ug/l
7.9
8.0
0.01
14
114
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
23
266
0.86
0.24
1.3
1.2
—
—
—
0
0
(44806071)
12
96
1.25
0.24
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
15
180
0.83
0.24
1.3
1.1
—
—
—
0
0
(3019225) pH of Specimen
303
2929
1.04
0.23
3.3
2.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
66
610
1.08
0.23
1.8
1.9
g/l
0.2
0.4
0.66
59
558
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
147
0.82
0.23
1.7
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
26
296
0.88
0.23
1.1
1.1
u/ml
6.8
6.6
—
6
44
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
38
1.32
0.23
1.2
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
30
266
1.13
0.22
1.8
2.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
27
305
0.88
0.22
1.6
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
252
0.87
0.21
1.6
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
221.7
—
0
11
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
120
1139
1.05
0.21
1.2
1.4
e6/l
637.8
4536.4
0.64
105
934
(3007919) Fasciola sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021661) Pineapple IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
96
1017
0.94
0.21
1.3
1.2
—
—
—
0
0
(4094501)
73
682
1.07
0.21
1.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
15
177
0.85
0.21
1.2
1.1
mg/g
4.5
4.8
0.28
15
171
(3049717) Cytology report of Urine Cyto stain
52
479
1.09
0.20
2.1
1.9
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
61
566
1.08
0.20
1.2
1.4
g/l
3.3
2.9
0.68
40
400
(3024139) IgG subclass 3 [Mass/volume] in Serum
61
566
1.08
0.20
1.2
1.4
g/l
0.4
0.4
0.51
42
400
(3027135) IgG subclass 1 [Mass/volume] in Serum
61
566
1.08
0.20
1.3
1.4
g/l
7.1
6.5
0.70
41
402
(3051387) C reactive protein [Mass/volume] in Capillary blood
85
799
1.06
0.20
3.5
3.2
mg/l
19.0
23.2
0.69
54
471
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
208
2159
0.96
0.20
1.5
1.5
nmol/l
0.4
0.5
0.52
173
1783
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
117
1.20
0.20
1.7
2.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
119
1131
1.05
0.20
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
61
656
0.93
0.20
2.8
4.4
u/ml
40.8
100.3
1.42
14
215
(46236302) HLA-C [Type] by High resolution typing
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
0
14
0.00
0.20
0.0
1.8
—
50.4
—
0
8
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3025296) Carrot IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
5.9
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
48
1.25
0.20
4.7
6.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
62
666
0.93
0.20
1.2
1.3
umol/l
5.7
5.9
0.24
55
623
(3043410) Blood group antigens tested for on Red Blood Cells
16
136
1.18
0.20
1.2
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
136
1.18
0.20
1.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
36
326
1.10
0.20
1.0
1.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
44
403
1.09
0.20
2.1
2.4
%
0.8
1.3
0.82
36
312
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
45
413
1.09
0.19
2.0
3.1
mg/l
24.1
24.3
0.03
33
343
(4062490)
61
568
1.07
0.19
1.3
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
21
239
0.88
0.19
1.2
1.2
pmol/l
16.6
16.1
0.07
21
217
(3010375) cycloSPORINE [Mass/volume] in Blood
17
146
1.16
0.19
17.5
25.8
ug/l
127.9
108.4
—
9
123
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
186
0.86
0.19
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
113
1076
1.05
0.18
1.2
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
15
175
0.86
0.18
1.3
2.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
347
1.10
0.18
1.4
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
33
299
1.10
0.18
1.4
1.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
63
589
1.07
0.18
1.2
1.1
mg/l
194.5
198.5
0.15
55
524
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
36
328
1.10
0.18
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
67
628
1.07
0.18
1.4
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
363
3721
0.97
0.18
2.3
2.3
au/ml
22.1
22.3
0.01
26
326
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
58
1.21
0.18
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
62
580
1.07
0.18
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
17
147
1.16
0.18
1.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
17
147
1.16
0.18
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
17
147
1.16
0.18
1.0
1.0
—
—
—
0
0
(44813793)
52
484
1.08
0.17
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
62
1.13
0.17
2.3
1.9
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
35
320
1.09
0.17
2.5
2.8
—
28.7
—
0
7
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
131
0.84
0.17
1.5
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
66
621
1.06
0.16
1.1
1.2
—
204.4
—
0
9
(3018133) Calcium [Moles/volume] in Urine
5
70
0.71
0.16
1.2
1.8
mmol/l
2.1
3.3
—
5
64
(3035637) Corticotropin [Mass/volume] in Plasma
60
563
1.07
0.16
1.5
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
657
6465
1.02
0.16
1.3
1.3
iu/l
25.1
24.1
0.35
578
5635
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
123
1180
1.04
0.16
1.6
1.7
titre
257.1
293.4
—
7
48
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
25
277
0.90
0.16
1.2
1.2
g/l
0.3
0.3
1.16
15
229
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
130
0.85
0.16
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
46
428
1.08
0.16
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
349
3569
0.98
0.15
1.8
2.1
e9/l
4.1
4.2
0.12
301
3087
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
54
506
1.07
0.15
2.2
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
130
1.15
0.15
2.2
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
29
264
1.10
0.15
1.7
1.7
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
9
78
1.15
0.15
1.8
1.9
mg/l
1.1
1.4
—
9
71
(3002256) Pathology report gross observation
596
5865
1.02
0.15
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
88
839
1.05
0.15
1.3
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
161
0.87
0.15
1.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
80
1.13
0.15
1.6
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
80
1.13
0.15
1.6
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
35
379
0.92
0.15
2.5
2.2
%
50.9
46.4
—
7
64
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
31
337
0.92
0.14
1.0
1.1
mg/l
287.7
302.7
0.66
31
308
(21494814) CD8 cells/100 lymphocytes in Specimen
14
160
0.87
0.14
2.4
2.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
29
315
0.92
0.13
1.3
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4696
47060
0.99
0.13
11.0
10.0
%
39.3
39.6
2.56
3755
39997
(3014051) Protein [Presence] in Urine by Test strip
96
1000
0.96
0.13
2.2
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
40
428
0.93
0.13
1.1
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
64
608
1.05
0.13
1.2
1.2
mg/l
32.6
35.0
0.19
51
512
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
107
0.84
0.13
2.8
2.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
112
1080
1.04
0.13
1.2
1.1
au/ml
21.6
11.3
—
7
83
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
142
1.13
0.12
3.2
3.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
18
200
0.90
0.12
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
38
406
0.94
0.12
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
35
374
0.94
0.11
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
111
1074
1.03
0.11
2.6
2.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
23
211
1.09
0.11
1.1
1.1
u/ml
74.2
50.0
0.64
23
206
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
157
0.89
0.11
1.3
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
370
3760
0.98
0.11
2.0
2.3
u/ml
23.9
31.6
2.19
360
3630
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
134
1.12
0.10
1.3
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
14
156
0.90
0.10
1.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
14
156
0.90
0.10
1.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
14
156
0.90
0.10
1.3
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
32
341
0.94
0.10
2.1
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1984
19939
0.99
0.10
1.9
1.9
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
5
45
1.11
0.09
1.0
1.0
u/ml
7.5
0.4
—
5
28
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
45
1.11
0.09
1.6
1.5
u/field
0.4
1.1
—
5
45
(3024263) Appearance of Synovial fluid
12
135
0.89
0.09
2.2
2.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
42
399
1.05
0.09
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
124
0.89
0.09
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
124
0.89
0.09
1.4
1.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
55
1.09
0.08
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
40
420
0.95
0.08
1.3
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
60
0.83
0.08
1.4
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
185
0.92
0.08
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
65
0.77
0.08
1.2
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
60
578
1.04
0.08
1.1
1.0
u/ml
0.4
1.7
1.08
18
164
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
123
0.89
0.08
1.4
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
123
0.89
0.08
1.4
1.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
66
1.06
0.08
1.0
1.0
—
—
—
0
0
(4133840)
12
133
0.90
0.07
1.4
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
12
133
0.90
0.07
1.1
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
74
0.81
0.07
1.5
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
117
1143
1.02
0.07
1.1
1.2
mmol/l
3.5
3.5
0.37
108
1076
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
69
668
1.03
0.07
1.1
1.2
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
8
76
1.05
0.07
1.5
2.1
pmol/l
34.0
37.9
—
8
71
(3011412) CD3 cells [#/volume] in Blood
45
469
0.96
0.07
3.0
2.6
e9/l
1.5
1.4
0.37
26
272
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
81
0.86
0.07
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
35
367
0.95
0.07
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
53
511
1.04
0.07
2.0
1.8
g/l
0.0
0.0
0.50
48
478
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
50
519
0.96
0.07
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
56
541
1.04
0.07
2.0
1.7
g/l
39.2
39.5
0.13
51
492
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
35
334
1.05
0.06
1.0
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
95
0.84
0.06
1.1
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
93
908
1.02
0.06
1.2
1.5
—
5.3
—
0
16
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
382
3783
1.01
0.06
1.3
1.3
miu/ml
223.6
237.5
0.31
181
1962
(40768795) Lymph node Pathology biopsy report
34
325
1.05
0.06
1.1
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
53
547
0.97
0.05
3.4
5.6
umol/l
353.4
373.6
0.52
42
466
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
131
1287
1.02
0.05
1.2
1.3
mg/l
440.7
431.1
0.05
125
1230
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
45
435
1.03
0.05
1.1
1.1
iu/ml
15.1
7.3
0.93
15
124
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
238
1.05
0.05
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
238
1.05
0.05
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
238
1.05
0.05
1.3
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
258
2604
0.99
0.04
1.2
1.2
u/l
10.0
10.7
0.36
219
2169
(3024980) IgG subclass 4 [Mass/volume] in Serum
84
824
1.02
0.04
1.3
1.5
g/l
0.6
0.6
0.03
62
628
(3016018) Differential panel - Cerebral spinal fluid
57
556
1.03
0.04
1.2
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
462
4648
0.99
0.04
2.0
2.0
nmol/l
379.5
379.4
0.00
432
4295
(3022217) INR in Platelet poor plasma by Coagulation assay
257
2548
1.01
0.04
8.8
7.5
inr
1.0
1.1
0.42
50
479
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
190
1.05
0.04
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
119
0.92
0.03
1.5
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1376
13724
1.00
0.03
1.7
1.7
pmol/l
96.7
99.6
1.72
821
7705
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
37
359
1.03
0.03
1.3
1.3
umol/l
10.2
9.3
0.56
37
341
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
108
0.93
0.03
2.2
2.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
231
1.04
0.02
1.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
345
3468
0.99
0.02
1.3
1.3
au/ml
28.6
32.5
0.19
13
133
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
35
341
1.03
0.02
1.1
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
1067
10690
1.00
0.02
5.3
6.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
14
133
1.05
0.01
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
38
388
0.98
0.01
1.5
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
50
492
1.02
0.01
3.1
2.7
ug/min
118.8
108.3
0.04
32
336
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1903
19012
1.00
0.01
2.3
2.2
nmol/l
73.4
73.0
0.28
1810
17996
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
18
187
0.96
0.01
2.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
21
217
0.97
0.01
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
465
4661
1.00
0.01
1.4
1.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
18
186
0.97
0.00
2.1
1.1
%
90.1
93.6
0.24
18
186
(3051651) Icteric interference index of Serum or Plasma
20
194
1.03
0.00
3.6
3.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
65
644
1.01
0.00
2.1
3.1
nmol/l
0.7
0.9
2.77
55
557
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
71
704
1.01
0.00
3.5
3.3
u/ml
14.0
293.8
0.81
61
595
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
115
0.96
0.00
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
115
0.96
0.00
1.0
1.3
—
—
—
0
0
(4024509)
34
338
1.01
0.00
1.5
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
16
155
1.03
0.00
2.5
4.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
195
1952
1.00
0.00
1.3
1.4
u/l
18.5
21.2
0.75
164
1625
(40768443) Skin Pathology biopsy report
166
1655
1.00
0.00
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
228
2285
1.00
0.00
3.5
3.4
ug/l
7.5
27.4
0.60
158
1531
(3045142) Bone marrow Pathology biopsy report
21
206
1.02
0.00
1.0
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
256
1.02
0.00
2.0
2.1
%
52.4
54.9
0.21
21
160
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
266
1.02
0.00
1.6
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
121
0.99
0.00
1.5
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
129
1.01
0.00
1.0
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
319
1.00
0.00
2.9
3.0
e6/l
798.6
872.7
0.31
16
138
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
283
2833
1.00
0.00
2.6
2.2
ml/min/173m2
75.3
82.4
1.79
109
1032
(3052592) Norovirus Ag [Presence] in Stool
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
0
7
0.00
0.00
0.0
2.7
—
0.2
—
0
7
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
72
0.97
0.00
1.0
1.2
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.7
—
967.6
—
0
7
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
6
65
0.92
0.00
2.0
2.2
mg/l
26.8
22.4
—
6
65
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
88
0.91
0.00
1.3
1.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.1
—
4.2
—
0
7
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
62
0.97
0.00
1.5
2.3
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
51
0.98
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_POOR_FETGRO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| O15_POOR_FETGRO | 1.13 [0.96, 1.34] | 0.154 |
| Birth year | 0.994 [0.99, 1.0] | 0.179 |
During the follow-up period (1.1.1998 — 31.12.2019), 262 out of 33445 females with O15_POOR_FETGRO died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have O15_POOR_FETGRO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.141% | No data |
| 5 | 0.614% | No data |
| 10 | 1.52% | No data |
| 15 | 3.059% | No data |
| 20 | 5.523% | No data |
Relationships between endpoints
↥Index endpoint: O15_POOR_FETGRO – Poor fetal growth
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data